// App-Quantinova.ai

P1348 : COMPARISON OF NATURAL KILLER CELL RECONSTITUTION AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION DEPENDING ON THE VARIANT OF T-CELL DEPLETION

Researchers

Presenter

  • Zoya Konova

Principal Investigators

  • Irina Galtseva

  • Nikolay Kapranov

  • Julia Davydova

  • Mikhail Drokov

  • Maria Dovidenko

  • Natalia Popova

  • Anna Dmitrova

  • Ulyana Maslikova

  • Olga Starikova

  • Ekaterina Mikhaltsova

  • Olga Koroleva

  • Darya Dubnyak

  • Feruza Omarova

  • Vera Vasilyeva

  • Larisa Kuzmina

  • Elena Parovichnikova

Medical Centers

  • Department of Intensive High-Dose Chemotherapy and Bone Marrow Transplantation,National Research Center for Hematology,

  • Department of immunochemotherapy with a day hospital for patients after BMT,National Research Center for Hematology,Moscow,Russia

  • Department of immunochemotherapy with a day hospital for patients after BMT,National Research Center for Hematology,Moscow,Russia

  • Laboratory of immunophenotyping of

  • Sector for the Study o

  • Head of National Research Center for Hematology,National Research Center for Hematology,Moscow,Russie, Fédération De

  • Sector for the Study of Immune Effects and Complications after BMT,National Research Center for Hematology,Moscow,Russia

  • Department of Intensive High-Dose Chemotherapy and Bone Marrow Transplantation,National Research Center for Hematology,Moscow,Russia

  • Head of National Research Center for Hematology,National Research Center for Hematology,Moscow,Russie, Fédération De

  • Laboratory of Immunophenotyping of blood and bone marrow cells, National Research Center for Hematology, Moscow, Russian Federation

  • Sector for the Study of Immune Effects and Complications after BMT,National Research Center for Hematology,Moscow,Russia

  • Laboratory of Immunophenotyping of blood and bone marrow cells, National Research Center for Hematology, Moscow, Russian Federation

  • Head of National Research Center for Hematology,National Research Center for He

  • Department of immunochemotherapy with a day hospital for patients after BMT,National Research Center for Hematology,Moscow,Russia

  • Department of Intensive High-Dose Chemotherapy and Bone Marrow Transplantation,National Research Center for Hematology,Moscow,Russia

Locations

  • United States

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

Biomarkers

  • Natural Killer cells

  • Breakpoint Cluster Region

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 14

  • Protein Tyrosine Phosphatase, Receptor Type C

  • Cluster of Differentiation 56

  • Cluster of differentiation 8A

  • Fc gamma RIIIa

  • Selectin L

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved